RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2009; 134(45): 2278-2282
DOI: 10.1055/s-0029-1241939
DOI: 10.1055/s-0029-1241939
Übersicht | Review article
Hypertensiologie
© Georg Thieme Verlag KG Stuttgart · New York
Baroreflexstimulation bei therapierefraktärer arterieller Hypertonie
Baroreflex stimulation for resistant arterial hypertensionWeitere Informationen
Publikationsverlauf
eingereicht: 1.7.2009
akzeptiert: 16.10.2009
Publikationsdatum:
29. Oktober 2009 (online)

Schlüsselwörter
therapierefraktäre Hypertonie - Baroreflexstimulation
Keywords
resistant hypertension - baroreflex hypertension therapy
Literatur
- 1 Bisognamo J, De Leeuw P, Bach D S. et al . Improved cardiac structure and function in early-stage heart failure with chronic treatment using an implantable Device: Results from the European and United States Trials of the Rheos system. J Cardiac Failure. 2008; 14 S48
- 2 Bisognamo J, De Leeuw P, Irwin E. et al . Long term baroreflex hypertension therapy significantly lowers ambulatory blood pressure in patients with resistant hypertension. Clin Hypertens. 2008; 10 A117
- 3 Calhoun D, Jones D, Textor S. et al . Resistant hypertension: diagnosis, evaluation, and treatment: a sientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008; 51 1403-1419
- 4 Chusid J G. Funktionelle Neurologie. Berlin, Heidelberg, New York; Springer Verlag 1978: 109-15
- 5 De Leeuw P, Bisognamo J, Bach D S. et al . Deviced-based reduction in blood pressure is associated with increased diameter of the left ventricular outflow tract: Results from the European and United States Trials of the Rheos( System. Circulation. 2008; 118 S887
- 6 De Leeuw P, Bisognamo J, Bach D S. et al . Improved cardiac structure and diastolic flow velocities in early-stage heart failure with chronic treatment using an implantable Device: Results from the European and United States Trials of the Rheos( System. J Am Coll Cardiol. 2009; 53 A188
- 7 De Leeuw P, Gangahar D, Bach D S. et al . Left ventricular reverse remodeling with chronic treatment using an implantable device: Results from the European and United States trials of the Rheos( Baroreflex Hypertension Therapy System. J Hypertens. 2008; 26 (Suppl 1) S471
- 8 De Leeuw P, Kroon A A, Scheffers I. et al . Baroreflex hypertension therapy with a chronically implanted system: Preliminary efficicay and safety results from the Rheos DEBuT-HT study in patients with resistant hypertension. J Hypertens. 2006; 24 (Suppl. 4) S300-S3001
- 9 Green A L, Wang S, Owen S L. et al . Stimulating the human midbrain to reveal the link between pain and blood pressure. Pain. 2006; 124 349-59
- 10 Griffith L CS, Schwartz S I. Electrical stimulation of the carotid sinus nerve in normotensive and renal hypertensive dogs. Circulation. 1963; 28 730
- 11 Hamberger C A, Carlsten A, Folkow B. et al . Some cardiovascular observation during radical neck dissection. Cancer. 1957; 10 938-43
- 12 Heusser K, Tank J, Diedrich A. et al . Electrical carotid sinus stimulation reduces symphatetic activity and blood pressure in patients with refractory hypertension. J Hypertens. 2009; 27 (Suppl 1) S 288
- 13 Lohmeier T E, Dwyer T M, Hildebrandt D A. et al . Suppression of the renin-angiotensin system contributes by prolonged baroreflex activation. Hypertension. 2004; 44 500
- 14 Lohmeier T E, Irwin E D, Rossing M A. et al . Prolonged activation of the baroreflex produces sustainede hypotension. Hypertension. 2004; 43 306-11
- 15 Mancia G, De Backer G, Dominczak A. et al . Guidelines for the mangagement of arterial hypertension: The Task Force for the Mangement of Arterial Hypertension of the European Society of Hypertesnion (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2207; 28 1462-1536
- 16 Mc Gubbin J W, Green J H, Page I H. Baroreceptor function in chronic renal hypertension. Circ Res. 1956; 4 2560-72
- 17 Middeke M. Hypertensiologie 2007. Dtsch Med Wochenschr. 2007; 132 1368-1370
- 18 Middeke M. Hypertensiologie 2009. Dtsch Med Wochenschr. 2009; 142 1312-15
-
19 National Institutes of
Health .Device Based Therapy in Hypertension Extension
Trial (DEBuT-HET). Available at: http://clinicaltrials.gov/ct2/show/NTC00710294.
- 20 Wolf-Maier K, Cooper R. et al . Hypertension prevalance and blood pressure levels in 6 European Countries; Canada, and the United States. J Am Med Assoc. 2003; 289 2363-69
- 21 Rosamond W, Flegal K, Furie K. et al . Heart disease and stroke statistics 2008 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation. 2008; 117 76-80
- 22 Rothstein M, De Leeuw P, Elletson M. et al .Chronic treatment of resistant hypertension with an implantable device: interim 2 year results of two studies of the Rheos( Hypertension System. Late-Breakiong Clinical Trials III: Emerging Technologies Session 407 ACC,. Orlando; March 30th, 2009
- 23 Schmidli S, Savolainen H, Eckstein F. et al . Acute device-based blood pressure reduction: Electrcal activation of the carotid baroreflex in patients undergoing elective carotid surgery. Vascular. 2007; 15 63-9
- 24 Scheffers I, Schmidli J, Kroon A A. et al . Sustained blood pressure reduction by baroreflex hypertension therapy with a chronically implanted system: long-term data from the Rheos DEBuT-HT study in patient with resistant hypertension. J Hypertens. 2007; 25 141-2
- 25 Scheffers I JM, Schmidli J, Kroon A A. et al . Sustained blood pressure reduction by baroreflex hypertension therapy with a chronically implated system: 3-year data from the Rheos Debut-Ht Study in patients with resistent hypertension. J Hypertens. 2209; 27 (Suppl 1) S421
- 26 Scheffers I, Kroon A, De Leeuw P. Renal haemodynamics during chronic therapy with electrical stimulation of the carotid sinus in human. J Hypertens. 2008; 28 (Suppl1) S465
- 27 Schwartz P J. et al . Long term vagal stimulation in patients with advanced heart failure. First experience in man. Eur J Heart Fail. 2008; 10 884-91
- 28 Peters T K. Therapeutische Blutdrucksenkung durch ein aktives Implantat: Ein neues Verfahren zur Behandlung der medikamentös therapierefraktären Hypertonie. J Hypert. 2008; 12 22-7
- 29 Wustmann K, Kucera J P, Scheffers I. et al . Effects of chronic baroreflex stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension. Hypertension. 2009; 54 530-6
- 30 Zucker I H, Hackley J F, Cornisch K G. et al . Chronic baroreflex activation enhances survival in dogs with pacing-induced heart failure. Hypertension. 2007; 50 1201-8
- 31 Cameron T. Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20 year literature review. J Neurosurg. 2004; 100 254-67
- 32 Kumar K, Buchser E, Linderoth B. et al . Avoiding complication from spinal cord stimulation: practical recommendations from an international panel of experts. Neuromodulation. 2007; 10 24-33
Dr. Siegfried Eckert
Kardiologische Klinik, Herz- und Diabeteszentrum
Nordrhein-Westfalen, Klinik der Ruhr-Universität Bochum
Georgstraße 11
32545 Bad Oeynhausen
Telefon: 05731/970
Fax: 05731/971874
eMail: seckert@hdz-nrw.de